EP3224276
NOVEL EPITOPE AS A TARGET FOR THERAPY OF INFLAMMATORY AUTOIMMUNE DISEASES AND GRAFT REJECTION
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
17.11.2015EP published:
17.6.2020EP application number:
15863095.4
EPO information:
European Patent Register
Max expiry date:
16.11.2035
Title:
NOVEL EPITOPE AS A TARGET FOR THERAPY OF INFLAMMATORY AUTOIMMUNE DISEASES AND GRAFT REJECTION
Timeline
Today
17.11.2015EP application
17.6.2020EP Publication
Owner
Name:
Technion Research & Development Foundation LimitedAddress:
Senate House Technion City, 3200004 Haifa, IL
Inventor
Name:
KARIN, NathanAddress:
3467703 Haifa, IL
Name:
WILDBAUM, GiziAddress:
2903649 Kiryat Yam, IL
Priority
Number:
201462083952 PDate:
25.11.2014Country:
US
Classification
Categories:
C07K 14/705, C07K 7/06, C07K 16/28, A61K 39/395, A61K 38/17, G01N 33/50, A61P 37/06, A61P 37/00, A61P 29/00